FAQ/Help |
Calendar |
Search |
Today's Posts |
|
![]() |
#1 | |||
|
||||
Legendary
|
Quote:
![]() White cells are our body's main means of fighting infection, and with a reduction that large, the medication would be inducing leukemia in the person taking it, leaving them open to potentially life threatening infections. For me, the negatives for this medication are piling up fast.
__________________
Eastern Australian Daylight Savings Time and my temperature . |
|||
![]() |
![]() |
![]() |
#2 | |||
|
||||
Elder
|
I heard its approved for dispensing on OCt 4. The cost is to be determined by the research value of the drug. strong rumors have it that it will be about 30k per year.
I will not be taking this med, or probably any other DMD in the short term. After my break from Copaxone I am feeling so much better. I just cant/wont go backwards to the land of resting in bed most of the day. If the disease takes me, so be it. I pray all those who chose it will be out dancing in the streets.
__________________
RRMS 3/26/07 . Betaseron 5/18/07 . Elevated LFTs Beta DC 7/07 Copaxone 8/7/07 . . |
|||
![]() |
![]() |
Reply |
|
|
![]() |
||||
Thread | Forum | |||
What I learned about fingolimod today | Multiple Sclerosis | |||
new information on Gilenia (Fingolimod) | Multiple Sclerosis | |||
Novartis had changed the name of Fingolimod to Gilenia (aka FTY720). | Multiple Sclerosis | |||
FTY720/Fingolimod | Multiple Sclerosis | |||
Fingolimod/FTY720 Research from ECTRIMS | Multiple Sclerosis |